Marco Fabbrini

Mr. Marco Fabbrini

Alma Mater Studiorum - University of Bologna
+2
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
ISItai Sharon
Itai Sharon
NQNarciso Martín Quijada
Narciso Martín Quijada
Edoardo PasolliEdoardo Pasolli
Edoardo Pasolli
Marco FabbriniMarco Fabbrini
Marco Fabbrini
FVFrancesco Vitali
Francesco Vitali
Silvia TurroniSilvia Turroni
Silvia Turroni
The core microbiome, which refers to a set of consistent microbial features across populations, is of major interest in microbiome research and has been addressed by numerous studies. Understanding the core microbiome can help identify elements that lead to dysbiosis, and lead to treatments for microbiome-related health states. However, defining the core microbiome is a complex task at several levels. In this review, we consider the current state of core human microbiome research. We consider the knowledge that has been gained, the factors limiting our ability to achieve a reliable description of the core human microbiome, and the fields most likely to improve that ability. DNA sequencing technologies and the methods for analyzing metagenomics and amplicon data will most likely facilitate higher accuracy and resolution in describing the microbiome. However, more effort should be invested in characterizing the microbiome’s interactions with its human host, including the immune system and nutrition. Other components of this holobiontic system should also be emphasized, such as fungi, protists, lower eukaryotes, viruses, and phages. Most importantly, a collaborative effort of experts in microbiology, nutrition, immunology, medicine, systems biology, bioinformatics, and machine learning is probably required to identify the traits of the core human microbiome.

23 June 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
Marco FabbriniMarco Fabbrini
Marco Fabbrini
Federica D'AmicoFederica D'Amico
Federica D'Amico
MBMonica Barone
Monica Barone
Gabriele ContiGabriele Conti
Gabriele Conti
Mariachiara MengoliMariachiara Mengoli
Mariachiara Mengoli
Silvia TurroniSilvia Turroni
Silvia Turroni
Nutraceuticals have been receiving increasing attention in the last few years due to their potential role as adjuvants against non-communicable chronic diseases (cardiovascular disease, diabetes, cancer, etc.). However, a limited number of studies have been performed to evaluate the bioavailability of such compounds, and it is generally reported that a substantial elevation of their plasma concentration can only be achieved when they are consumed at pharmacological levels. Even so, positive effects have been reported associated with an average dietary consumption of several nutraceutical classes, meaning that the primary compound might not be solely responsible for all the biological effects. The in vivo activities of such biomolecules might be carried out by metabolites derived from gut microbiota fermentative transformation. This review discusses the structure and properties of phenolic nutraceuticals (i.e., polyphenols and tannins) and the putative role of the human gut microbiota in influencing the beneficial effects of such compounds.

19 October 2023 in Blood
Verified
Journal Article
Open access
PDF file
Riccardo MasettiRiccardo Masetti
Riccardo Masetti
DLDavide Leardini
Davide Leardini
EMEdoardo Muratore
Edoardo Muratore
Marco FabbriniMarco Fabbrini
Marco Fabbrini
Federica D'AmicoFederica D'Amico
Federica D'Amico
Silvia TurroniSilvia Turroni
Silvia Turroni
The correlation existing between gut microbiota diversity and survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) has so far been studied in adults. Pediatric studies question whether this association applies to children as well. Stool samples from a multicenter cohort of 90 pediatric allo-HSCT recipients were analyzed using 16S ribosomal RNA amplicon sequencing to profile the gut microbiota and estimate diversity with the Shannon index. A global-to-local networking approach was used to characterize the ecological structure of the gut microbiota. Patients were stratified into higher- and lower-diversity groups at 2 time points: before transplantation and at neutrophil engraftment. The higher-diversity group before transplantation exhibited a higher probability of overall survival (88.9% ± 5.7% standard error [SE] vs 62.7% ± 8.2% SE; P = .011) and lower incidence of grade 2 to 4 and grade 3 to 4 acute graft-versus-host disease (aGVHD). No significant difference in relapse-free survival was observed between the 2 groups (80.0% ± 6.0% SE vs 55.4% ± 10.8% SE; P = .091). The higher-diversity group was characterized by higher relative abundances of potentially health-related microbial families, such as Ruminococcaceae and Oscillospiraceae. In contrast, the lower-diversity group showed an overabundance of Enterococcaceae and Enterobacteriaceae. Network analysis detected short-chain fatty acid producers, such as Blautia, Faecalibacterium, Roseburia, and Bacteroides, as keystones in the higher-diversity group. Enterococcus, Escherichia-Shigella, and Enterobacter were instead the keystones detected in the lower-diversity group. These results indicate that gut microbiota diversity and composition before transplantation correlate with survival and with the likelihood of developing aGVHD.

Verified
Journal Article
Open access
PDF file
RFRoberta Fiume
Roberta Fiume
Irene FaenzaIrene Faenza
Irene Faenza
BSBhavwanti Sheth
Bhavwanti Sheth
Alessandro PoliAlessandro Poli
Alessandro Poli
MVMagdalena C Vidalle
Magdalena C Vidalle
NDNullin Divecha
Nullin Divecha
Polyphosphoinositides (PPIns) are a family of seven lipid messengers that regulate a vast array of signalling pathways to control cell proliferation, migration, survival and differentiation. PPIns are differentially present in various sub-cellular compartments and, through the recruitment and regulation of specific proteins, are key regulators of compartment identity and function. Phosphoinositides and the enzymes that synthesise and degrade them are also present in the nuclear membrane and in nuclear membraneless compartments such as nuclear speckles. Here we discuss how PPIns in the nucleus are modulated in response to external cues and how they function to control downstream signalling. Finally we suggest a role for nuclear PPIns in liquid phase separations that are involved in the formation of membraneless compartments within the nucleus.

8 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Federica D'AmicoFederica D'Amico
Federica D'Amico
Anna PerroneAnna Perrone
Anna Perrone
SRSimone Rampelli
Simone Rampelli
SCSara Coluccelli
Sara Coluccelli
MBMonica Barone
Monica Barone
Silvia TurroniSilvia Turroni
Silvia Turroni
Epithelial ovarian cancer (EOC) is one of the most lethal and silent gynecological tumors. Despite appropriate surgery and chemotherapy, relapse occurs in over half of patients with a poor prognosis. Recently, the gut microbiota (GM) was hypothesized to influence the efficacy of anticancer therapies, but no data are available in EOC. Here, by 16S rRNA gene sequencing and inferred metagenomics, we profiled the GM of EOC patients at diagnosis and reconstructed its trajectory along the course of neoadjuvant or adjuvant chemotherapy up to follow-up. Compared to healthy subjects, the GM of EOC patients appeared unbalanced and severely affected by chemotherapy. Strikingly, discriminating patterns were identified in relation to the therapeutic response. Platinum-resistant patients showed a marked temporal reduction in GM diversity and increased instability with loss of health-associated taxa and increased proportions of Coriobacteriaceae and Bifidobacterium. Notably, most of these microorganisms are lactate producers, suggesting increased lactate production as supported by inferred metagenomics. In contrast, the GM of platinum-sensitive patients appeared overall more diverse and stable and enriched in lactate utilizers from the Veillonellaceae family. In conclusion, we identified potential GM signatures of therapeutic outcome in EOC patients, which could open up new opportunities for cancer prognosis and treatment.

1 January 2023 in Microbiome Research Reports
Verified
Journal Article
Open access
PDF file
SRSara Roggiani
Sara Roggiani
Mariachiara MengoliMariachiara Mengoli
Mariachiara Mengoli
Gabriele ContiGabriele Conti
Gabriele Conti
Marco FabbriniMarco Fabbrini
Marco Fabbrini
PBPatrizia Brigidi
Patrizia Brigidi
Silvia TurroniSilvia Turroni
Silvia Turroni
Although research on the role of the gut microbiota (GM) in human health has sharply increased in recent years, what a “healthy” gut microbiota is and how it responds to major stressors is still difficult to establish. In particular, anticancer chemotherapy is known to have a drastic impact on the microbiota structure, potentially hampering its recovery with serious long-term consequences for patients’ health. However, the distinguishing features of gut microbiota recovery and non-recovery processes are not yet known. In this narrative review, we first investigated how gut microbiota layouts are affected by anticancer chemotherapy and identified potential gut microbial recovery signatures. Then, we discussed microbiome-based intervention strategies aimed at promoting resilience, i.e., the rapid and complete recovery of a healthy gut microbial network associated with a better prognosis after such high-impact pharmacological treatments.